Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma

Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma

Abstract Background Currently, no standard of care or therapies have been established for patients with advanced HCC. We evaluated the efficacy and safety of conventional transarterial chemoembolization using gelatin sponges or microspheres plus lipiodol-doxorubicin (cTACE) and TACE with doxorubicin...

Full description

Bibliographic Details
Main Authors: Yi-Sheng Liu, Chia-Ying Lin, Ming-Tsung Chuang, Yi-Shan Tsai, Chien-Kuo Wang, Ming-Ching Ou
Format: Article
Language:English
Published: BMC 2018-08-01
Series:BMC Gastroenterology
Subjects:
Drug-eluting bead transcatheter arterial chemoembolization
DEB-TACE
Hepatocellular carcinoma
Transcatheter arterial chemoembolization
TACE
Online Access:http://link.springer.com/article/10.1186/s12876-018-0848-1

Internet

http://link.springer.com/article/10.1186/s12876-018-0848-1

Similar Items